Literature DB >> 11158218

Expression of nephrin in pediatric kidney diseases.

Jaakko Patrakka1, Vesa Ruotsalainen2, Ilkka Ketola1, Christer Holmberg1, Markku Heikinheimo1,3, Karl Tryggvason4, Hannu Jalanko1.   

Abstract

Nephrin is a podocyte cell adhesion protein located at the slit diaphragm area of the kidney glomerulus. Mutations in the nephrin gene (NPHS1) lead to congenital nephrosis, suggesting that nephrin is essential for the glomerular filtration barrier. This prompted this study of the expression of nephrin in acquired pediatric kidney diseases using in situ hybridization and immunohistochemistry. In situ hybridization for nephrin mRNA was performed in biopsy samples from patients with proteinuria caused by minimal change nephrosis, focal segmental glomerulosclerosis, and membranous nephropathy. The expression of nephrin mRNA was evaluated by grading the signal intensity visually and by counting the number of grains in separate glomeruli. No significant difference was observed in these samples as compared with controls. Immunostaining for nephrin was performed using antibodies directed against extra- and intracellular parts of the molecule. Nephrin staining gave a linear pattern along the glomerular capillary loops. In minimal change nephrosis, focal segmental glomerulosclerosis, and membranous nephropathy, the distribution of nephrin was similar to that in controls. In proliferative forms of glomerulonephritides (Henoch-Schönlein nephritis, IgA nephropathy, postinfectious and membranoproliferative glomerulonephritis), crescents and sclerotic lesions were negative for nephrin, and mesangial proliferation led to a scattered and sparse staining pattern. The staining pattern of nephrin was compared to that of ZO-1, a component of the cytoplasmic face of the slit diaphragm. The distributions of these two proteins in capillary tufts were similar in all disease entities studied. In conclusion, immunohistochemistry and in situ hybridization did not reveal major alterations in the expression of nephrin in proteinuric kidney diseases in children. Further studies are needed for more precise evaluation of the role of nephrin in these diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158218     DOI: 10.1681/ASN.V122289

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  23 in total

Review 1.  Pathogenesis of proteinuria: lessons learned from nephrin and podocin.

Authors:  Hannu Jalanko
Journal:  Pediatr Nephrol       Date:  2003-06       Impact factor: 3.714

2.  Glomerular podocytes express type 1 adenylate cyclase: inactivation results in susceptibility to proteinuria.

Authors:  Zhijie Xiao; Liqun He; Minoru Takemoto; Hannu Jalanko; Guy C Chan; Daniel R Storm; Christer Betsholtz; Karl Tryggvason; Jaakko Patrakka
Journal:  Nephron Exp Nephrol       Date:  2010-12-24

3.  Expression profile of nephrin, podocin, and CD2AP in Chinese children with MCNS and IgA nephropathy.

Authors:  Jianhua Mao; Yang Zhang; Lizhong Du; Yuwen Dai; Chunhu Yang; Li Liang
Journal:  Pediatr Nephrol       Date:  2006-08-29       Impact factor: 3.714

4.  Role of nephrin in cell junction formation in human nephrogenesis.

Authors:  V Ruotsalainen; J Patrakka; P Tissari; P Reponen; M Hess; M Kestilä; C Holmberg; R Salonen; M Heikinheimo; J Wartiovaara; K Tryggvason; H Jalanko
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

Review 5.  Pathogenesis of proteinuria in idiopathic minimal change disease: molecular mechanisms.

Authors:  Gabriel Cara-Fuentes; William L Clapp; Richard J Johnson; Eduardo H Garin
Journal:  Pediatr Nephrol       Date:  2016-07-06       Impact factor: 3.714

6.  Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study.

Authors:  Ali Ramezani; Joseph M Devaney; Scott Cohen; Maria R Wing; Richard Scott; Susan Knoblach; Rishi Singhal; Lilian Howard; Jeffrey B Kopp; Dominic S Raj
Journal:  Eur J Clin Invest       Date:  2015-04       Impact factor: 4.686

Review 7.  C-peptide: a new potential in the treatment of diabetic nephropathy.

Authors:  J Wahren; K Ekberg; B Samnegård; B L Johansson
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

8.  Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.

Authors:  Vinita Agrawal; Narayan Prasad; Manoj Jain; Rakesh Pandey
Journal:  Clin Exp Nephrol       Date:  2013-02-02       Impact factor: 2.801

9.  Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant.

Authors:  Huma Fatima; Marcus J Moeller; Bart Smeets; Hai-Chun Yang; Vivette D D'Agati; Charles E Alpers; Agnes B Fogo
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-23       Impact factor: 8.237

10.  Expression of nephrin, podocin, alpha-actinin, and WT1 in children with nephrotic syndrome.

Authors:  Na Guan; Jie Ding; Jingjing Zhang; Jiyun Yang
Journal:  Pediatr Nephrol       Date:  2003-09-05       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.